Tvardi Therapeutics, Inc. (TVRD) Financials
TVRD Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 32.1 million | 11.1 million |
| Sept. 30, 2025 | 39.0 million | 11.2 million |
| June 30, 2025 | 43.8 million | 10.8 million |
| March 31, 2025 | 27.8 million | 42.9 million |
TVRD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | -5.7 million | 353000 |
| Sept. 30, 2025 | -4.3 million | 339000 |
| June 30, 2025 | -8.9 million | -719000 |
| March 31, 2025 | -4.7 million | 1.4 million |
TVRD Net Income
No data available :(
TVRD Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 30.8 million | - | 201000 |
| Sept. 30, 2025 | 36.5 million | - | 115000 |
| June 30, 2025 | 41.0 million | - | 254000 |
| March 31, 2025 | 22.3 million | 35.8 million | 280000 |
TVRD Shares Outstanding
TVRD Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | - | 5.5 million | 2.1 million | - |
| Sept. 30, 2025 | - | 3.6 million | 2.3 million | - |
| June 30, 2025 | - | 5.8 million | 3.1 million | - |
| March 31, 2025 | - | 319000 | 4.6 million | - |
TVRD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | - | - |
| Sept. 30, 2025 | - | - |
| June 30, 2025 | - | 47000 |
| March 31, 2025 | 2.6 million | - |
TVRD
Price: $2.63
52 week price:
Earnings Per Share: -3.26 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 27.1 million